IPOPLUS

1,269

-7.9 -0.62%

17 Jun 2026

NSE Listed · Pharmaceuticals

Dr Reddy S Laboratories (DRREDDY)

Volume: 13,363Avg Vol 1W: 3,49,833Avg Vol 1M: 5,57,12752W Range:1,148.41,379.7
₹1,269 0.62%
Key Ratios
Updated 2h ago
Market Cap₹1,06,328 Cr
Current Price₹1,269
Previous Close₹1,276.9
High / Low (52w)₹1,379.7 / ₹1,148.4
Volume13,363
Avg Vol (1W)3,49,833
Avg Vol (1M)5,57,127
Stock P/E16.87
Book Value₹453.79
Dividend Yield0.63%
ROE11.07%
ROA7.15%
Revenue (TTM)
Revenue Growth16.54%
Profit Margin12.49%
Total Debt₹380 Cr
Shares Outstanding83 Cr
Face Value₹1
EPS (TTM)₹2.65
P/B2.82
Debt / Equity0.2
50 DMA₹1,295.54
200 DMA₹1,271.05
Day change-0.62%
Price Chart
1,269 1.59% · 1Y
135511561.6Cr
2025-10-21
2026-06-16

20-day avg volume: 5.4L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 17% YoY.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹7,546 Cr₹8,753 Cr₹8,828 Cr₹8,572 Cr₹8,528 Cr₹8,381 Cr₹8,038 Cr₹7,696 Cr₹7,114 Cr₹7,237 Cr₹6,903 Cr₹6,758 Cr₹6,315 Cr₹6,790 Cr₹6,332 Cr₹5,233 Cr₹5,475 Cr₹5,338 Cr₹5,787 Cr₹4,945 Cr₹4,768 Cr₹4,942 Cr₹4,911 Cr₹4,427 Cr₹4,449 Cr
EBITDA₹301 Cr₹1,635 Cr₹1,829 Cr₹1,988 Cr₹2,065 Cr₹1,952 Cr₹1,987 Cr₹1,937 Cr₹1,661 Cr₹1,866 Cr₹1,948 Cr₹1,883 Cr₹1,357 Cr₹1,674 Cr₹1,631 Cr₹1,493 Cr₹280 Cr₹977 Cr₹1,271 Cr₹559 Cr₹827 Cr₹299 Cr₹891 Cr₹916 Cr₹749 Cr
Net Profit₹221 Cr₹1,210 Cr₹1,347 Cr₹1,418 Cr₹1,593 Cr₹1,414 Cr₹1,256 Cr₹1,392 Cr₹1,310 Cr₹1,381 Cr₹1,482 Cr₹1,405 Cr₹960 Cr₹1,244 Cr₹1,114 Cr₹1,189 Cr₹97 Cr₹709 Cr₹996 Cr₹380 Cr₹557 Cr₹28 Cr₹772 Cr₹595 Cr₹781 Cr
EPS2.6514.5216.1817.0219.116.9475.2583.4878.5382.8188.9184.3657.6874.7666.9871.495.8342.6559.8822.8933.511.6746.435.7847.03
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹33,741 Cr₹28,905 Cr₹25,725 Cr₹22,030 Cr₹19,339 Cr₹18,138 Cr
EBITDA₹7,941 Cr₹7,357 Cr₹6,154 Cr₹3,087 Cr₹2,933 Cr₹1,928 Cr
Net Profit₹5,655 Cr₹5,578 Cr₹4,507 Cr₹2,183 Cr₹1,952 Cr₹2,026 Cr
EPS67.7966.92270.9131.21117.34121.99
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹49,427 Cr₹38,864 Cr₹32,285 Cr₹29,747 Cr₹26,617 Cr₹23,225 Cr
Total Liabilities₹15,499 Cr₹10,609 Cr₹8,999 Cr₹10,535 Cr₹8,975 Cr₹7,627 Cr
Equity₹33,927 Cr₹28,255 Cr₹23,286 Cr₹19,212 Cr₹17,642 Cr₹15,599 Cr
Total Debt₹380 Cr₹380 Cr₹0 Cr₹380 Cr₹380 Cr₹130 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹6,642 Cr₹6,548 Cr₹6,959 Cr₹3,555 Cr₹4,142 Cr₹3,695 Cr
Investing₹-5,808 Cr₹-4,028 Cr₹-4,137 Cr₹-2,639 Cr₹-2,266 Cr₹-492 Cr
Financing₹1,891 Cr₹-376 Cr₹-2,686 Cr₹-242 Cr₹-30 Cr₹-2,516 Cr
Free Cash Flow₹6,642 Cr₹6,548 Cr₹6,959 Cr₹2,089 Cr₹3,168 Cr₹3,695 Cr
Shareholding
Promoter 26.63% Institutions 51.86% Public 21.03%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search